Question from Deputy Ken O’Flynn - PQ 39690-26
Deputy O'Flynn asked if any substance misuse teams in HSE South West operate without direct consultant psychiatrist input. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked if any substance misuse teams in HSE South West operate without direct consultant psychiatrist input. Read the HSE response.
Deputy O'Flynn asked about the waiting list for HSE substance misuse service operating in HSE South West. Read the HSE response.
Deputy O'Flynn asked about the Irish reimbursement assessment process for omaveloxolone (Skyclarys®). Read the HSE response.
Deputy Nolan asked about the waiting lists for scoliosis treatment and spinal surgery for children in the midlands. Read the HSE response.
Deputy O'Flynn asked about the data-quality assurance and human-error mitigation across clinical and operational systems in the HSE. Read the HSE response.
Deputy O'Flynn asked about clinical governance for treatments funded under the treatment abroad scheme. Read the HSE response.
Deputy O'Flynn asked if the HSE maintains a national register of data-quality incidents. Read the HSE response.
Deputy O'Flynn asked about the reimbursement of omaveloxolone (skyclarys). Read the HSE response.
Deputy O'Flynn asked how are reimbursement decisions for high-cost orphan medicines are financially planned. Read the HSE response.
Deputy O'Flynn asked about the reimbursement of omaveloxolone (Skyclarys). Read the HSE response.